Previous 10 | Next 10 |
Cancer Patients Across the U.S. to Benefit from GenesisCare's Partnership with ViewRay, Inc. Leading Oncology Provider Adds MRIdian® MR-Guided Therapy Systems to the U.S. PR Newswire FORT MYERS, Fla. , June 24, 2021 /PRNewswire/ -- GenesisCare ȁ...
ViewRay Announces Election of Karen N. Prange to its Board of Directors PR Newswire CLEVELAND , June 11, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced the election of Karen N. Prange to its Board of Directors by ViewRay's stockholders at its...
American Hospital in Istanbul, Turkey Purchases MRIdian® MRI-Guided Radiation Therapy System MD Anderson's International Radiation Treatment Center Expands Offering with Selection of ViewRay's MRIdian System for Adaptive Radiotherapy PR Newswire CLEVELAND , ...
ViewRay® to Present at the Jefferies 2021 Virtual Healthcare Conference PR Newswire CLEVELAND , May 17, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Jefferies 2021 Virtual Healthcare Conference. ...
Kahn Brothers’ 13F portfolio value increased from $579M to $646M this quarter. Stakes in VOXX International and BlackBerry were decreased during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~45% of the 13F holdings....
The following slide deck was published by ViewRay, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: ViewRay, Inc. 2021 Q1 - Results - Earnings Call Presentation
Shares of ViewRay (NASDAQ: VRAY) vaulted 13.8% higher on Friday after the medical-device maker announced its first-quarter results following the market close on Thursday. ViewRay's total revenue in the first quarter rose 8.4% year over year to $15.5 million. That easily beat the...
ChemoCentryx hurt by a series of downgradesLate yesterday, ChemoCentryx (CCXI) announced its narrow win at the FDA’s expert panel meeting on the potential approval for avacopan in the treatment of vasculitis associated with antineutrophil cytoplasmic autoantibody ((ANCA)).At least...
iBio (IBIO) +33% on COVID-19 study update.Orgenesis (ORGS) +11% on Q1 results.Chemomab Therapeutics (CMMB) +12%.T2 Biosystems, Inc. (TTOO) +11% on Q1 results.ViewRay (VRAY) +12%.Epizyme (EPZM) +11% on Q1 results.CureVac N.V. (CVAC) +9%.Roku (ROKU) +9% on Q1 results.Da...
Image source: The Motley Fool. ViewRay, Inc. (NASDAQ: VRAY) Q1 2021 Earnings Call May 06, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: ViewRay, Inc. (VRAY) Q1 2021 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...